Brief: eFFECTOR Therapeutics Announces $7.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
May 26 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS ANNOUNCES $7.5 MILLION REGISTERED
DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
* EFFECTOR THERAPEUTICS - ENTERED DEFINITIVE DEAL WITH
SINGLE
INSTITUTIONAL INVESTOR FOR PURCHASE AND SALE OF 11.5MLN SHARES
OF ITS COMMON STOCK
* EFFECTOR THERAPEUTICS INC - DEFINITIVE AGREEMENT AT
PURCHASE
PRICE OF $0.655 PER SHARE
* EFFECTOR THERAPEUTICS INC - GROSS PROCEEDS TO CO FROM
OFFERING
ARE EXPECTED TO BE ABOUT $7.5 MILLION
Source text for Eikon: ID:nGNX25dbDg
Further company coverage: EFTR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright